Oxiracetam

Oxiracetam is a racetam nootropic people discuss for studying, clearer thinking and mild stimulation. Some describe easier concentration or less morning grogginess; others notice little, become tired or feel overstimulated. The disagreement includes how much people take, whether choline helps, and whether an early benefit lasts.

What Oxiracetam is

• A distinct nootropic, also called ISF 2522. Oxiracetam belongs to the racetam discussion alongside piracetam and aniracetam. ISF 2522 and ISF-2522 are verified research names; “oxi” is an informal abbreviation in these threads. It is a non-peptide compound, not Noopept or a choline supplement. Official context Reddit
• S-oxiracetam is a more specific identity. The “S” names one mirror-image form of the molecule. A study of that form cannot automatically describe a capsule labeled only oxiracetam. The reports here do not verify the chemical contents of the products people used. Official context Reddit

What people hope to notice

• Study focus without a dramatic high. A calculus student described sustained study focus, while a different discussion described mental clarity and smoother energy. These are self-assessments; an easier-feeling study session does not establish better recall, accuracy or grades. Reddit Reddit
• Less grogginess, or more detail in music. One morning user preferred a subtle lift to phenylpiracetam’s stronger feel. Another first-time user noticed music detail but then became too sleepy to work. Sensory changes and useful concentration can move in different directions. Personal report Reddit

Doses people discuss

These are reported amounts, not instructions. mg means milligrams; 1,000 mg equals 1 gram. Single administrations and daily totals are different, and an unstated route is left unstated.

• 500 mg in one oral-capsule account. The capsule user combined this with 200 mg caffeine, 200 mg L-theanine and 250 mg CDP-choline, and remained unsure of any benefit after mathematics work. Replies favoring higher amounts are advice, not evidence that this person needed more. Reddit
• 150–200 mg, 350 mg and 800 mg describe different accounts. One person preferred 150–200 mg on selected mornings; another preferred 350 mg after DMAE and found 800 mg once or twice jittery. Another person reported 800 mg at 07:00 and noon, totaling 1,600 mg that day. These posts do not explicitly establish route or formulation. Personal report Reddit
• 750 mg can accompany benefit or fog. A study-focused account paired it with 300 mg of a choline source. Another person reported fog with 750 mg plus Alpha-GPC, and still felt unwell without Alpha-GPC. Neither combination defines a standard amount or safe ceiling. Reddit Personal report

Half-life

• Eight hours is a circulated forum claim. A commenter in a first-use thread supplies this number without a study or measurement method. Half-life means the time for a measured drug level to fall by half; it does not mean eight hours of focus or that all effects have ended. Separate human research appears below. Reddit

Onset: when people notice a change

• About an hour can mean subtle focus, fog or no clear effect. The 500 mg capsule author was uncertain about extra focus at that point. In the 750 mg plus 300 mg Alpha-GPC account, fog and fatigue appeared around one hour. Neither establishes a reliable time for cognitive benefit. Reddit Personal report

Duration: how long it feels active

• Four hours of studying, tapering toward six, in one report. The 750 mg/choline account describes that window. Another commenter estimated six hours for oxiracetam versus two to three for Noopept, without specifying amounts or routes. These are personal comparisons, not clearance measurements or guaranteed work periods. Reddit
• Unwanted wakefulness can outlast the useful feeling. A first-time user described fatigue, anxiety and alertness nearly 12 hours after the last administration. They later reported improvement and reconsidered the episode as panic; the full update matters when interpreting that long window. Personal report

Cycles, repeated use and tolerance

• Intermittent use and weekday schedules both appear. Examples include two days weekly and selected mornings over about a month. A commenter in the capsule discussion described five days on and weekends off while also reporting fading sensitivity. No report establishes an effective reset interval. Reddit Personal report Reddit
• A fading benefit does not prove a need to escalate. A 2023 author alternated with piracetam after 1,000 mg daily seemed less effective, but supplied no successful follow-up. A different thread includes early benefit turning into tiredness and a year-long user developing headaches, slowness and irritability. Tolerance, changed circumstances and adverse effects are not distinguished by these accounts. Personal report Reddit

Cautions that change the picture

• Stimulation can become discomfort, and clarity can become fatigue. The inspected accounts include jitters, eye fatigue, sleepiness and impaired concentration. They cannot tell us how often these occur, or whether oxiracetam, a companion substance or another factor caused them. Reddit Personal report Reddit
• Kidney function affects persistence. A human study found much longer elimination in patients with impaired kidney function. This is a concrete reason an online timing estimate may not fit a person; it is not a basis for adjusting amounts from a forum chart. Official context
• Product and medication uncertainty remain. These reports do not verify capsule contents, long-term safety or interaction risks. Some include prescription medication or several nootropics, so uneventful use in one account cannot establish that another combination is safe. Reddit Reddit Reddit

What the community disagreements add

• Choline is not a settled fix. One commenter said 400 mg Alpha-GPC improved concentration, while also taking Effexor XR and a prescription stimulant. The fog reporter changed Alpha-GPC from 300 mg to 100 mg to none: the last attempt was less unpleasant, but concentration remained poor. That sequence does not diagnose a choline shortage or excess. Reddit Personal report
• A serious-sounding first report needs its later correction. The first-use author listed 550 mg followed by 330 mg, coffee, tyrosine, eggs and CDP-choline; later replies made the choline timing unclear. They initially feared kidney problems, then said bloodwork checked out and attributed much of the episode to panic. That is one uncertain story, not confirmed kidney injury or proof of harmlessness. Personal report
• Noopept and phenylpiracetam comparisons are preferences. One commenter preferred oxiracetam’s longer felt window; another favored Noopept for reading. The morning user found phenylpiracetam stronger but oxiracetam more suitable for their grogginess. These comparisons do not establish a potency conversion, a winner for cognition or protection from cross-tolerance. Reddit Personal report
• Subtle effects and nonresponse can be hard to distinguish. The capsule user could not confidently identify a benefit despite doing mathematics, and did not hear the advertised change in music. That uncertainty belongs beside enthusiastic accounts. The available sample cannot estimate a responder percentage or confirm a “logic-enhancing” effect. Reddit

What human research and official records add

• An older clinical trial does not answer the healthy-student question. A four-week placebo-controlled study included 40 patients with late-life cognitive problems. Its abstract reports improvement signals, but differences between groups on the geriatric assessment scale did not reach statistical significance. This is limited clinical context, not proof of better studying. Official context
• Measured half-lives belong to their exact study. After a single oral 800 mg administration, a study of 20 patients with renal impairment reported terminal plasma half-lives of 10.6–68.1 hours, with longer persistence in worse impairment. The publisher summary was inspected; the full paper was not. Those figures are not a healthy-user range or felt duration. Official context
• The newer six-hour result concerns S-oxiracetam. A Phase I study in healthy Chinese volunteers reported oral S-oxiracetam half-lives of 6.12–6.60 hours and blood peaks at 0.75–1 hour; food delayed the peak to three hours. The abstract described mild or moderate adverse events. These are blood measurements and short-term tolerability findings, not onset, memory benefit or general safety guarantees. Official context
• Regulatory recognition is different from approval. FDA’s 2019 letter treated one seller’s oxiracetam as an unapproved new drug and said it was not a dietary supplement. A separate May 2025 orphan designation for Duchenne muscular dystrophy still shows “Not FDA Approved for Orphan Indication” in the accessed record. Neither supports marketing it as an approved cognitive enhancer. Official context Official context